MAM
Martingale Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.44M | Buy |
112,340
+23
| +0% | +$499 | 0.06% | 265 |
|
|
2025
Q1 | $2.72M | Buy |
112,317
+1,350
| +1% | +$32.7K | 0.07% | 228 |
|
|
2024
Q4 | $2.32M | Buy |
110,967
+23,890
| +27% | +$499K | 0.06% | 280 |
|
|
2024
Q3 | $1.73M | Buy |
+87,077
| New | +$1.73M | 0.04% | 347 |
|
|
2022
Q4 | – | Sell |
-56,476
| Closed | -$725K | – | 835 |
|
|
2022
Q3 | $725K | Sell |
56,476
-45,226
| -44% | -$581K | 0.01% | 534 |
|
|
2022
Q2 | $714K | Buy |
+101,702
| New | +$714K | 0.01% | 563 |
|